Published on in Vol 6, No 2 (2017): February

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)

Journals

  1. Johnson B, Cadeddu J. Current opinion in urology 2017. Current Opinion in Urology 2018;28(2):166 View
  2. Sano M, DeWitt M, Teeter S, Xing L. Optimization of a single insertion electrode array for the creation of clinically relevant ablations using high-frequency irreversible electroporation. Computers in Biology and Medicine 2018;95:107 View
  3. Zhou W, Arellano R. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation. Journal of Vascular and Interventional Radiology 2018;29(7):943 View
  4. Rubin A, Usta O, Schloss R, Yarmush M, Golberg A. Selective Inactivation ofPseudomonas aeruginosaandStaphylococcus epidermidiswith Pulsed Electric Fields and Antibiotics. Advances in Wound Care 2019;8(4):136 View
  5. Vogel J, van Veldhuisen E, Alles L, Busch O, Dijk F, van Gulik T, Huijzer G, Besselink M, van Lienden K, Verheij J. Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study. Technology in Cancer Research & Treatment 2019;18:153303381987689 View
  6. Salagierski M, Wojciechowska A, Zając K, Klatte T, Thompson R, Cadeddu J, Kaouk J, Autorino R, Ahrar K, Capitanio U. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. European Urology Oncology 2018;1(5):395 View
  7. Zondervan P, Buijs M, De Bruin D, van Delden O, Van Lienden K. Available ablation energies to treat cT1 renal cell cancer: emerging technologies. World Journal of Urology 2019;37(3):445 View
  8. Agnass P, van Veldhuisen E, van Gemert M, van der Geld C, van Lienden K, van Gulik T, Meijerink M, Besselink M, Kok H, Crezee J. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review. International Journal of Hyperthermia 2020;37(1):486 View
  9. Van Bruwaene S, Namdarian B, Challacombe B, Eddy B, Billiet I. Introducing new technology safely into urological practice. World Journal of Urology 2018;36(4):543 View
  10. Buijs M, Zondervan P, de Bruin D, van Lienden K, Bex A, van Delden O. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study. Urologic Oncology: Seminars and Original Investigations 2019;37(3):183.e1 View
  11. Macefield R, Wilson N, Hoffmann C, Blazeby J, McNair A, Avery K, Potter S. Outcome selection, measurement and reporting for new surgical procedures and devices: a systematic review of IDEAL/IDEAL-D studies to inform development of a core outcome set. BJS Open 2020;4(6):1072 View
  12. Richards H, Cousins S, Scroggie D, Elliott D, Macefield R, Hudson E, Mutanga I, Shah M, Alford N, Blencowe N, Blazeby J. Examining the application of the IDEAL framework in the reporting and evaluation of innovative invasive procedures: secondary qualitative analysis of a systematic review. BMJ Open 2024;14(5):e079654 View

Books/Policy Documents

  1. del Pilar Laguna Pes M, Rosette J. Diagnosis and Surgical Management of Renal Tumors. View
  2. Steinberg R, Cadeddu J. Interventional Urology. View